Back to Search
Start Over
Vertex Pharmaceuticals price target lowered by $3 at RBC Capital, here's why
- Source :
- The Fly. June 11, 2024
- Publication Year :
- 2024
-
Abstract
- RBC Capital lowered the firm's price target on Vertex Pharmaceuticals to $421 from $424 and keeps a Sector Perform rating on the shares after the company presented new data at [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.797316560